Education
About Us
Working with TipRanks
Follow Us
Morepen Laboratories Limited (IN:MOREPENLAB)
:MOREPENLAB
MOREPENLAB Stock Chart & Stats
₹41.52
-₹1.18(-1.56%)
At close: 4:00 PM EST
₹41.52
-₹1.18(-1.56%)
Day’s Range― - ―
52-Week Range₹40.01 - ₹87.67
Previous CloseN/A
Volume3.34M
Average Volume (3M)88.30K
Market Cap
₹22.41B
Enterprise Value₹27.04B
Total Cash (Recent Filing)₹1.27B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.7
Beta2.08
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.48%
Share Statistics
EPS (TTM)0.75
Shares Outstanding547,953,700
10 Day Avg. Volume126,704
30 Day Avg. Volume88,304
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)2.29
Price to Sales (P/S)1.45
P/FCF Ratio-28.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Morepen Laboratories Limited News
MOREPENLAB FAQ
What was Morepen Laboratories Limited’s price range in the past 12 months?
Morepen Laboratories Limited lowest stock price was ₹40.01 and its highest was ₹87.67 in the past 12 months.
What is Morepen Laboratories Limited’s market cap?
Morepen Laboratories Limited’s market cap is ₹22.41B.
When is Morepen Laboratories Limited’s upcoming earnings report date?
Morepen Laboratories Limited’s upcoming earnings report date is Feb 05, 2026 which is in 49 days.
How were Morepen Laboratories Limited’s earnings last quarter?
Morepen Laboratories Limited released its earnings results on Nov 14, 2025. The company reported ₹0.746 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.746.
Is Morepen Laboratories Limited overvalued?
According to Wall Street analysts Morepen Laboratories Limited’s price is currently Overvalued.
Does Morepen Laboratories Limited pay dividends?
Morepen Laboratories Limited pays a Annually dividend of ₹0.2 which represents an annual dividend yield of 0.48%. See more information on Morepen Laboratories Limited dividends here
What is Morepen Laboratories Limited’s EPS estimate?
Morepen Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Morepen Laboratories Limited have?
Morepen Laboratories Limited has 547,953,700 shares outstanding.
What happened to Morepen Laboratories Limited’s price movement after its last earnings report?
Morepen Laboratories Limited reported an EPS of ₹0.746 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.215%.
Which hedge fund is a major shareholder of Morepen Laboratories Limited?
Currently, no hedge funds are holding shares in IN:MOREPENLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Morepen Laboratories Limited
Morepen Laboratories Limited (MOREPENLAB) is a prominent Indian pharmaceutical and healthcare company that specializes in the development, manufacturing, and marketing of a diverse range of products including active pharmaceutical ingredients (APIs), finished formulations, diagnostic products, and herbal healthcare solutions. Operating primarily in the pharmaceutical sector, the company is known for its strong focus on research and development, enabling it to deliver high-quality products to both domestic and international markets.
Technical Analysis
Gufic Biosciences Limited
―
Medi Assist Healthcare Services Limited
―
Panacea Biotec Limited
―
RPG Life Sciences Limited
―
Unichem Laboratories Limited
―